Pulmonary hypertension and its management in patients undergoing non-cardiac surgery (Q38255425)

1 September 2017

1 reference

title

Pulmonary hypertension and its management in patients undergoing non-cardiac surgery (English)

1 reference

1 September 2017

0 references

pulmonary hypertension

1 reference

S A Pilkington

1

1 reference

1 September 2017

D Taboada

series ordinal

2

1 reference

1 September 2017

G Martinez

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

29 September 2014

1 reference

1 September 2017

1 reference

1 September 2017

70

1 reference

1 September 2017

56-70

1 reference

1 September 2017

1

1 reference

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

1 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Severe pulmonary hypertension complicates postoperative outcome of non-cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary arterial hypertension: epidemiology and registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the In

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Definitions and diagnosis of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Updated Clinical Classification of Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension due to left heart diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary arterial hypertension in France: results from a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension: the science behind the disease spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Oxidative stress in severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Alterations of cellular bioenergetics in pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Genetics and genomics of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Macitentan and morbidity and mortality in pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Tadalafil therapy for pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Riociguat for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Transplantation for idiopathic pulmonary arterial hypertension: improvement in the lung allocation score era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

The mechanism of effort syncope in primary pulmonary hypertension and cyanotic congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Haemodynamic evaluation of pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

World Health Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Anesthesia and pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Isoflurane and desflurane impair right ventricular-pulmonary arterial coupling in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Sevoflurane alters right ventricular performance but not pulmonary vascular resistance in acutely instrumented anesthetized pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Anesthesia for noncardiac surgery in adults with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension and right ventricular dysfunction: physiology and perioperative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Comparison of the effects of propofol and isoflurane anaesthesia on right ventricular function and shunt fraction during thoracic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Morphine, opioids, and the feline pulmonary vascular bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

An analysis of remifentanil in the pulmonary vascular bed of the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Thoracic epidural anaesthesia disrupts the protective mechanism of homeometric autoregulation during right ventricular pressure overload by cardiac sympathetic blockade: a randomised controlled animal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Therapeutic impact of intra-operative transoesophageal echocardiography during noncardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary arterial hypertension: pathophysiology and anesthetic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension: a contraindication to the use of {beta}-adrenoceptor blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pulmonary hypertension in pregnancy: critical care management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

Atrial flutter and fibrillation in patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FANAE.12831

21 January 2018

Identifiers

DOI

10.1111/ANAE.12831

1 reference

1 September 2017

1 reference